Kronik Obstrüktif Akciğer Hastalığında Kardiyovasküler Risk Faktörleri

References (1)

1. Okutan O, Ayten Ö. Kronik Obstrüktif Akciğer Hastalığı ve Komorbiditeler. Solunum 2012; 14: 181-3. [CrossRef] 2. Bilgin S, Güngör S, Yalçınsoy M, Tekiner E, Akkaya E. Cardiovascular risk factoss in patients with chronic obstructive pulmonary disease. 16th ERS Annual Congress, Munich, Germany, 2006; 28 Supp 50: 624-3656. 3. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-9. [CrossRef] 4. Akpınar EE, Akpınar S, Ertek S, Sayın E, Gülhan M. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk Toraks 2012; 60: 230-7. [CrossRef] 5. Lam KB, Jordan RE, Jiang CQ, Thomas GN, Miller MR, Zhang WS, et al. Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study. Eur Respir J 2010; 35: 317-23. [CrossRef] 6. Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25: 226-32. [CrossRef] 7. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797-9. [CrossRef]